Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer
- Conditions
- Non Small Cell Lung Cancer Stage IIIB
- Interventions
- Drug: Standard of Care
- First Posted Date
- 2018-03-21
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- BioMarck Pharmaceuticals, Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT03472053
- Locations
- 🇮🇳
Vardhman Mahavir Medical College & Hospital, New Delhi, Delhi, India
🇮🇳Unique Hospital and Research Institute, Surat, Gujarat, India
🇮🇳Aadhar Health Institute, Hisar, Hariyana, India
Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS
- Conditions
- Respiratory Distress Syndrome, Adult
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2020-06-25
- Lead Sponsor
- BioMarck Pharmaceuticals, Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT03202394
- Locations
- 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States
🇺🇸University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States
🇺🇸Wake Forest University, Winston-Salem, North Carolina, United States
Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD
- Conditions
- COPDChronic Obstructive Pulmonary Disease
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2011-02-10
- Lead Sponsor
- BioMarck Pharmaceuticals, Ltd.
- Target Recruit Count
- 172
- Registration Number
- NCT00648245
- Locations
- 🇺🇸
Pulmonary Associates, Glendale, Arizona, United States
🇺🇸Greater Los Angeles Healthcare System, Los Angeles, California, United States
🇺🇸Bay Pines VA Heatlhcare System, Bay Pines, Florida, United States